Tradestie Institutional Equity Comparison Engine
GCL vs NIVF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GCL Overall Edge
GCL Captures Institutional Edge (2โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GCL Global Holdings Ltd Ordinary Shares (GCL) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, GCL trades at N/M Forward P/E with -5.5% operating margin (+53.8% YoY revenue) versus NIVF at N/M Forward P/E and -238.2% operating margin (-4.7% YoY). In options structure, GCL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NIVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
GCL N/M vs NIVF N/M Fwd P/E
Growth & Margin Winner
GCL
Op Margin -5.5% vs -238.2% ยท YoY +53.8% vs -4.7%
Momentum & Technical Winner
GCL
1Y -28.4% vs -44.8% ยท 52W Pos 57% vs 5%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GCL
NASDAQ
GCL Global Holdings Ltd Ordinary Shares
Services-Prepackaged Software
$1.16
-2.93% 1D
Market Cap
$153.0M
1M Return
+33.16%
1Y Return
-28.4%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 50.0
Fund 33.0
Flow 50.0
Mom 40.0
NIVF
NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.20
-11.33% 1D
Market Cap
$369,508
1M Return
-26.52%
1Y Return
-44.83%
Forward P/E
N/M
Unified AI Score
45.8 / 100
HOLD
Tech 50.0
Fund 44.0
Flow 50.0
Mom 45.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GCL -28.4%
NIVF -44.83%
Spread: +16.43 pp (GCL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GCL TTM Op. Margin: -5.5%
NIVF TTM Op. Margin: -238.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GCL vs NIVF. Trailing 12-month operating profitability (GCL -5.5% vs NIVF -238.2%) and valuation multiples (GCL N/M vs NIVF N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GCL | NIVF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $153.0M | $369,508 | Larger Scale | GCL |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +53.8% | -4.7% | Higher Growth | GCL |
| Operating Margin (TTM) Profitability | -5.5% | -238.2% | Higher Margin | GCL |
| Net Profit Margin Profitability | -10.5% | 24.2% | Higher Margin | NIVF |
| Return on Equity (ROE) Capital Efficiency | -67.3% | 5.5% | Higher ROE | NIVF |
| 52-Week Range Position Momentum | 57% ($0โ$2) | 5% ($0โ$3) | Stronger Trend | GCL |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 75% Vol | 0.07ฮฒ ยท 3093% Vol | Lower Realized Risk | GCL |
| Unified Institutional Score Composite Signal | 31.6 / 100 (SELL) | 45.8 / 100 (HOLD) | Higher Composite | NIVF |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GCL vs NIVF Buy Guide
GCL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NIVF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GCL nor NIVF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.